Intravenous infusion of GLP-1(7–36)amide improved global and regional function of the left ventricle, assessed by velocity, strain, and strain rate, and improved the post-ischemic myocardial stunning, particularly in ischemic segments, in patients with coronary artery disease and ischemic dysfunction induced by dobutamine stress echocardiography [175]. Here, GLP1R is linked to coronary artery disorder.